Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T16:18:25.030Z Has data issue: false hasContentIssue false
  • English
  • Français

Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity

Published online by Cambridge University Press:  15 May 2009

C. R. Davies ,
E. A. Llanos-Cuentas ,
S. D. M. Pyke  and
C. Dye
C. R. Davies
Affiliation:
Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
E. A. Llanos-Cuentas
Affiliation:
Instituto de Medicina Tropical ‘Alexander von Humboldt’, Universidad Peruana Cayetano Heredia, A.P. 4314, Lima 100, Peru
S. D. M. Pyke
Affiliation:
Department of Epidemiology and Population Sciences, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
C. Dye
Affiliation:
Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A prospective longitudinal survey of cutaneous leishmaniasis (Leishmania peruviana) was carried out in Peru on a study population of 4716 persons living in 38 villages (Departments of Lima, Ancash and Piura). Demographic and clinical data were collected from all individuals, and a Montenegro skin test (MST) was carried out on 72% (3418) of the study population. Each household was revisited at 3-monthly intervals for up to 2 years to detect new leishmaniasis cases; 497 people received a second MST at the end of the study. Analysis of the epidemiological data indicated that (i) 17% (16/94) of all infections were subclinical, (ii) this percentage increased significantly with age, (iii) clinical infections led to 73·9 % protective immunity (95 % C.I. 53·0–85·5 %) and relatively permanent MST responsiveness (recovery rate = 0·0098/year; 95% C.I. 0·000–0·020/year), (iv) sub-clinical infections led to protective immunity, which was positively correlated with their MST induration size (increasing by 17·9% per mm; P < 0·0001), and a mean MST recovery rate of 0·114/year (4/421 man-months), and (v) recurrent leishmaniasis was dominated by reactivations, not by reinfections.

Type
Research Article
Information
Epidemiology & Infection , Volume 114 , Issue 2 , April 1995 , pp. 297 - 318
Copyright
Copyright © Cambridge University Press 1995

References

REFERENCES

1.Chang, K-P, Chaudhari, G, Fong, D. Molecular determinants of Leishmania virulence. Ann Rev Microbiol 1990; 44: 499–529.CrossRefGoogle ScholarPubMed
2.Kahl, LP.Byram, JE, David, JR. Leishmania braziliensis isolated from cutaneous and mucocutaneous lesions of patients residing in Tres Bracos, Bahia, Brazil differ in virulence for the golden hamster. Trans R Soc Trop Med Hyg 1990; 84: 783–4.CrossRefGoogle ScholarPubMed
3.Davies, CR, Fernandez, M, Paz, L, Roncal, N, Llanos-Cuentas, A. Lutzomyia verrucarum can transmit Leishmania peruviana, the aetiological agent of Andean cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1993; 87: 603–6.CrossRefGoogle ScholarPubMed
4.Lara, ML, Layrisse, Z, Scorza, JV et al. , Immunogenetics of human American cutaneous leishmaniasis: study of HLA haplotypes in 24 families from Venezuela. Human Immunol 1991; 30: 129–35.CrossRefGoogle ScholarPubMed
5.Petzl-Erler, ML, Belich, MP, Queiroz-Telles, F. Association of mucosal leishmaniasis with HLA. Human Immunol 1991; 32: 254–60.CrossRefGoogle ScholarPubMed
6.Cerf, BJ.Jones, TC, Badaro, R et al. , Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis 1987; 156: 1030–3.CrossRefGoogle ScholarPubMed
7.Ayesta, C, Argüello, C.Hernández, AG. Leishmania braziliensis: cell surface differences in promastigotes of pathogenic and nonpathogenic strains. Exp Parasitol 1985; 59: 185–91.CrossRefGoogle ScholarPubMed
8.Greenblatt, CL, Handman, E, Mitchell, GF, Battye, FL, Schnur, LF, Snary, D. Phenotypic diversity of cloned lines of Leishmania major promastigotes. Z Parasitenkd 1985; 71: 141–57.CrossRefGoogle ScholarPubMed
9.de Marzochi, MC.Coutinho, SG, Sabroza, PC, de Souza, WJS. Reação de imunofluorescencia indireta e intradermorreação para leishmaniose tegumentar Americana em moradores na área de Jacarepagua (Rio de Janeiro). Estudo comparative dos resultados observados em 1974 e 1978. Rev Inst Med Trop São Paulo 1980; 22: 149–55.Google Scholar
10.Jones, TC.Johnson, WD, Barretto, AC et al. , Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 1987; 156: 73–83.CrossRefGoogle ScholarPubMed
11.Furuya, M, Mimori, T, Gomez, EA, de Coronel, VV, Kawabata, M, Hashiguchi, Y. Epidemiological survey of leishmaniasis using skin test and ELISA in Ecuador. Japan J Trop Med Hyg 1989; 17: 331–8.CrossRefGoogle Scholar
12.Oliveiro-Neto, MP, Pirmez, C, Rangel, E, Schubach, A, Grimaldi, G. An outbreak of American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in a periurban area of Rio de Janeiro. Brazil: clinical and epidemiological studies. Mem Inst Oswaldo Cruz 1989; 83: 427–35.CrossRefGoogle Scholar
13.Marrano, NN, Mata, LJ, Durack, DT. Cutaneous leishmaniasis in rural Costa Rica. Trans R Soc Trop Med Hyg 1989; 83: 340.CrossRefGoogle ScholarPubMed
14.Weigle, KA.Valderrama, L, Arias, AL, Santrich, C, Saravia, NG. Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am J Trop Med Hyg 1991; 44: 260–71.CrossRefGoogle ScholarPubMed
15.Weigle, KA, Santrich, C.Martinez, F, Valderamma, L, Saravia, NG. Epidemiology of cutaneous leishmaniasis in Colombia: a longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations. J Infect Dis 1993; 168: 699–708.CrossRefGoogle ScholarPubMed
16.Barretto, AC, Cuba-Cuba, CA.Marsden, PD, Vexenat, JA.de Belder, M. Características epidemiológicas da leishmaniose tegumentar Americana em una região endêmica do estado da Bahia, Brasil. 1. Leishmaniose humana. Bol Oficina Sanit Panam 1981; 90: 415–24.Google Scholar
17.Scorza, JV.Valera, M, Moreno, E, Jaimes, R. Encuesta epidemiólogica sobre leishmaniasis cutánea. Un estudio en Mérida, Venezuela. Bol Oficina Sanit Panam 1983; 95: 118–33.Google ScholarPubMed
18.Hashiguchi, Y.Arias, O, Maciel, J, Furuya, M, Kawabata, M. Cutaneous leishmaniasis in south-eastern Paraguay: a study of an endemic area at Limoy. Trans R Soc Trop Med Hyg 1991; 85: 592–4.CrossRefGoogle Scholar
19.Passes, VMA, Falcao, AL, Marzochi, MCA et al. , Epidemiological aspects of American cutaneous leishmaniasis in a periurban area of the Metropolitan region of Bel Horizonte. Minas Gerais, Brazil. Mem Inst Osw Cruz 1993; 88: 103–10.CrossRefGoogle Scholar
20.Menezes, JA, Reis, VLL, Coura, JR. Inquérito preliminar pela reação de Montenegro em populaçãao rural no município de Trajano de Moraes. Rev Soc Bras Med Trop 1972; 6: 171–6.CrossRefGoogle Scholar
21.Pessôa, SB, Lopes, JA. Sobre a intradermorreação de Montenegro em região endêmica de leishmaniose tegumentar e visceral. Rev Inst Med Trop São Paulo 1963; 5: 170–5.Google Scholar
22.Dye, C. Leishmaniasis epidemiology: the theory catches up. Parasitology 1992; 104: S7–S18.CrossRefGoogle ScholarPubMed
23.Manson-Bahr, PC. Diagnosis. In: Peters, W, Killick-Kendrick, R, eds. The leishmaniases in biology and medicine. Vol II. Clinical aspects and control. London: Academic Press, 1987: 703–29.Google Scholar
24.Nascimento, DSB, Alcantara-Neves, NM, Muniz, MEB, Nunes, SF, Paranhos, M, de Carvalho, LCP. Induction and modulation of the immune response to Leishmania by Montenegro's skin test. Trans R Soc Trop Med Hyg 1993; 87: 91–3.CrossRefGoogle ScholarPubMed
25.Aebischer, T. Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitol Today 1994; 10: 25–8.CrossRefGoogle ScholarPubMed
26.Saravia, N, Weigle, K, Segura, I et al. , Recurrent lesions in human Leishmania braziliensis infection: reactivation or reinfection? Lancet 1990; 336: 398–402.CrossRefGoogle ScholarPubMed
27.Cuba-Cuba, CA, Evans, D, Rosa, AC, Marsden, PD. Clonal variation within a mucosal isolate derived from a patient with Leishmania braziliensis infection. Rev Inst Med Trop São Paulo 1991; 33: 343–50.CrossRefGoogle Scholar
28.Llanos-Cuentas, EA. Risk factors associated with the transmission of Andean cutaneous leishmaniasis [PhD Thesis]. London University, UK, 1993.Google Scholar
29.Dujardin, JC, Llanos-Cuentas, A, Cáceres, A et al. , Molecular karyotype variation in Leishmania (Viannia) peruviana: indication of geographical populations in Peru distributed along a North–South cline. Ann Trop Med Parasitol 1993; 87: 335–47.CrossRefGoogle ScholarPubMed
30.Perez, JE, Villaseca, P, Cáceres, A et al. , Leishmania peruviana isolated from the sandfly Lutzomyia peruensis and a sentinel hamster in the Huayllacayan Valley, Ancash, Peru. Trans R Soc Trop Med Hyg 1991; 85: 60.CrossRefGoogle Scholar
31.World Health Organisation. Control of the leishmaniases. Report of a WHO expert committee. World Health Organisation Technical Series No. 793. Geneva: WHO, 1990.Google Scholar
32.Davies, CR, Llanos-Cuentas, A, Canales, J et al. , The fall and rise of Andean cutaneous leishmaniasis: transient impact of the DDT campaign in Peru. Trans R Soc Trop Med Hyg 1994; 88: 389–93.CrossRefGoogle ScholarPubMed
33.Villaseca, P, Llanos-Cuentas, A, Perez, E, Davies, CR. A comparative field study of the relative importance of Lutzomyia peruensis and Lu. verrucarum as vectors of cutaneous leishmaniasis in the Peruvian Andes. Am J Trop Med Hyg 1993; 49: 260–9.CrossRefGoogle ScholarPubMed
34.Guevara, P, Ramírez, JL, Rojas, E, Scorza, JV, Gonzales, N, Anez, N. Leishmania braziliensis in blood 30 years after cure. Lancet 1993; 341: 1341.CrossRefGoogle ScholarPubMed
35.Herrer, A. Estudios sobre leishmaniasis tegumentaria en el Peru. IV. Observaciones epidemiológicas sobre la uta. Rev Med Exp 1951; 8: 45–86.Google Scholar
36.Seyedi-Rushti, MA, Nadim, A. Re-establishment of cutaneous leishmaniasis after cessation of anti-malaria spraying. Trop Geogr Med 1975; 27: 79–82.Google Scholar
37.Mayrinck, W, Melo, MN, da Costa, CA et al. , Intradermorreaçãao de Montenegro na leishmaniose tegumentar Americana apos terapêutica antimonial. Rev Inst Med Trop São Paulo 1976; 18: 182–5.Google Scholar
38.Gutierrez, Y, Salinas, GH, Palma, P, Valderrama, LB, Santrich, CV, Saravia, NG. Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection. Am J Trop Med Hyg 1991; 45: 281–9.CrossRefGoogle ScholarPubMed
39.Conceiçao-Silva, F, Dórea, RCC, Pirmez, C, Schubach, A, Coutinho, SG. Quantitative study of Leishmania braziliensis reactive T cells in peripheral blood and in the lesions of patients with American cutaneous leishmaniasis. Clin Exp Immunol 1990; 79: 221–6.CrossRefGoogle Scholar
40.Saravia, NG, Valderrama, L, Labrada, M et al. , The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis 1989; 159: 725–35.CrossRefGoogle ScholarPubMed
41.Weigle, KA, Santrich, C, Martinez, F, Valderamma, L, Saravia, NG. Epidemiology of cutaneous leishmaniasis in Colombia: environmental and behavioural risk factors for infection, clinical manifestations, and pathogenicity. J Infect Dis 1993; 168: 709–14.CrossRefGoogle ScholarPubMed
42.de Resell, RA, de Duran, RJ, Rossell, O, Rodríguez, AM. Is leishmaniasis ever cured ? Trans R Soc Tron Med Hyg 1992: 86: 251–3.CrossRefGoogle Scholar